NEWS | RESEARCH
Blood Biomarker May Help Predict Long-Term Mortality Following Hip Fracture .
Could a blood test identify older patients at particularly high risk following hip fracture surgery? An observational study from China found that elevated preoperative P-selectin, a protein associated with platelet activation and vascular inflammation, was associated with more than threefold higher mortality hazard over 3 years. The findings suggest that inflammatory and thrombotic pathways may contribute to poor long-term outcomes after fragility fractures. However, the biomarker requires external validation before it can inform routine risk stratification or treatment decisions.
Read the full News article from Scienmag
Read Article
DISCLAIMER
This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.
